DK0656001T3 - Nye 2-substituerede indan-2-mercaptoacetylamid-tricycliske derivater til anvendelse som enkefalinasehæmmere - Google Patents
Nye 2-substituerede indan-2-mercaptoacetylamid-tricycliske derivater til anvendelse som enkefalinasehæmmereInfo
- Publication number
- DK0656001T3 DK0656001T3 DK93917323T DK93917323T DK0656001T3 DK 0656001 T3 DK0656001 T3 DK 0656001T3 DK 93917323 T DK93917323 T DK 93917323T DK 93917323 T DK93917323 T DK 93917323T DK 0656001 T3 DK0656001 T3 DK 0656001T3
- Authority
- DK
- Denmark
- Prior art keywords
- new
- tricyclic derivatives
- enkephalinase inhibitors
- substituted indan
- mercaptoacetylamide
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/06—Antiglaucoma agents or miotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/10—Antioedematous agents; Diuretics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
- C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
- C07D513/04—Ortho-condensed systems
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Ophthalmology & Optometry (AREA)
- Pain & Pain Management (AREA)
- Psychiatry (AREA)
- Urology & Nephrology (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Hospice & Palliative Care (AREA)
- Addiction (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Indole Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US93483392A | 1992-08-24 | 1992-08-24 | |
| US08/078,787 US5420271A (en) | 1992-08-24 | 1993-06-17 | 2-substituted indane-2-mercaptoacetylamide tricyclic derivatives useful as inhibitors of enkephalinase |
| PCT/US1993/006920 WO1994004531A1 (en) | 1992-08-24 | 1993-07-23 | Novel 2-substituted indane-2-mercaptoacetylamide tricyclic derivatives useful as inhibitors of enkephalinase |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK0656001T3 true DK0656001T3 (da) | 2000-04-03 |
Family
ID=26760940
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK93917323T DK0656001T3 (da) | 1992-08-24 | 1993-07-23 | Nye 2-substituerede indan-2-mercaptoacetylamid-tricycliske derivater til anvendelse som enkefalinasehæmmere |
Country Status (18)
| Country | Link |
|---|---|
| US (2) | US5491141A (da) |
| EP (1) | EP0656001B1 (da) |
| JP (1) | JP3427937B2 (da) |
| AT (1) | ATE184604T1 (da) |
| AU (1) | AU679452B2 (da) |
| CA (1) | CA2141563C (da) |
| DE (1) | DE69326474T2 (da) |
| DK (1) | DK0656001T3 (da) |
| ES (1) | ES2139669T3 (da) |
| FI (1) | FI950842A (da) |
| GR (1) | GR3031602T3 (da) |
| HU (1) | HUT71246A (da) |
| IL (1) | IL106748A0 (da) |
| MX (1) | MX9305093A (da) |
| NO (1) | NO303635B1 (da) |
| NZ (1) | NZ254656A (da) |
| TW (1) | TW404949B (da) |
| WO (1) | WO1994004531A1 (da) |
Families Citing this family (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5508272A (en) * | 1993-06-15 | 1996-04-16 | Bristol-Myers Squibb Company | Compounds containing a fused bicycle ring and processes therefor |
| US6635632B1 (en) | 1996-12-23 | 2003-10-21 | Athena Neurosciences, Inc. | Cycloalkyl, lactam, lactone and related compounds, pharmaceutical compositions comprising same, and methods for inhibiting β-amyloid peptide release and/or its synthesis by use of such compounds |
| US6683075B1 (en) | 1996-12-23 | 2004-01-27 | Athena Neurosciences, Inc. | Cycloalkyl, lactam, lactone and related compounds, pharmaceutical compositions comprising same, and methods for inhibiting β-amyloid peptide release and/or its synthesis by use |
| US6509331B1 (en) | 1998-06-22 | 2003-01-21 | Elan Pharmaceuticals, Inc. | Deoxyamino acid compounds, pharmaceutical compositions comprising same, and methods for inhibiting β-amyloid peptide release and/or its synthesis by use of such compounds |
| US6774125B2 (en) | 1998-06-22 | 2004-08-10 | Elan Pharmaceuticals, Inc. | Deoxyamino acid compounds, pharmaceutical compositions comprising same, and methods for inhibiting β-amyloid peptide release and/or its synthesis by use of such compounds |
| US6958330B1 (en) | 1998-06-22 | 2005-10-25 | Elan Pharmaceuticals, Inc. | Polycyclic α-amino-ε-caprolactams and related compounds |
| US6528505B1 (en) | 1998-06-22 | 2003-03-04 | Elan Pharmaceuticals, Inc. | Cyclic amino acid compounds pharmaceutical compositions comprising same and methods for inhibiting β-amyloid peptide release and/or its synthesis by use of such compounds |
| US6569851B1 (en) | 1998-06-22 | 2003-05-27 | Elan Pharmaceutials, Inc. | Cycloalkyl, lactam, lactone and related compounds, pharmaceutical compositions comprising same, and methods for inhibiting β-amyloid peptide release and/or its synthesis by use of such compounds |
| US6552013B1 (en) | 1998-06-22 | 2003-04-22 | Elan Pharmaceuticals, Inc. | Deoxyamino acid compounds, pharmaceutical compositions comprising same, and methods for inhibiting β-amyloid peptide release and/or its synthesis by use of such compounds |
| MX2011012479A (es) | 2009-05-22 | 2012-03-06 | Abbott Lab | Moduladores de los receptores 5-ht y metodos de uso de los mismos. |
| RU2015140748A (ru) | 2010-05-21 | 2018-12-26 | Эббви Инк. | Модуляторы 5-нт рецепторов и способы их применения |
| EP3414239A2 (en) | 2016-02-05 | 2018-12-19 | Denali Therapeutics Inc. | Inhibitors of receptor-interacting protein kinase 1 |
| PL3552017T3 (pl) | 2016-12-09 | 2022-08-08 | Denali Therapeutics Inc. | Związki użyteczne jako inhibitory RIPK1 |
| MX2024008648A (es) | 2022-01-12 | 2024-09-23 | Denali Therapeutics Inc | Formas cristalinas de (s)-5-bencil-n-(5-metil-4-oxo-2,3,4,5-tetrah idropirido [3,2- b][1,4]oxacepin-3-il)-4h-1,2,4-triazol-3-carboxam ida. |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4584294A (en) * | 1984-11-07 | 1986-04-22 | Merck & Co., Inc. | Fused tricyclic lactams as angiotensin converting enzyme inhibitors and as antihypertensive agents |
| FR2611712B1 (fr) * | 1987-02-26 | 1989-06-23 | Roussel Uclaf | Nouveaux derives n-substitues de l'alpha-mercaptomethyl benzene propanamide, leur procede de preparation, leur application a titre de medicaments et les compositions les renfermant |
| US4879309A (en) * | 1988-09-27 | 1989-11-07 | Schering Corporation | Mercapto-acylamino acids as antihypertensives |
| ZA902661B (en) * | 1989-04-10 | 1991-01-30 | Schering Corp | Mercapto-acyl amino acids |
| CA2053340C (en) * | 1990-10-18 | 2002-04-02 | Timothy P. Burkholder | Mercaptoacetylamide derivatives useful as inhibitors of enkephalinase and ace |
| AU657793B2 (en) * | 1991-09-27 | 1995-03-23 | Merrell Pharmaceuticals Inc. | Novel 2-substituted indane-2-carboxyalkyl derivatives useful as inhibitors of enkephalinase and ACE |
| CA2078758C (en) * | 1991-09-27 | 2003-12-09 | Alan M. Warshawsky | 2-substituted indane-2-mercaptoacetylamide derivatives useful as inhibitors of enkephalinase and ace |
| US5420271A (en) * | 1992-08-24 | 1995-05-30 | Merrell Dow Pharmaceuticals, Inc. | 2-substituted indane-2-mercaptoacetylamide tricyclic derivatives useful as inhibitors of enkephalinase |
-
1993
- 1993-07-23 CA CA002141563A patent/CA2141563C/en not_active Expired - Fee Related
- 1993-07-23 NZ NZ254656A patent/NZ254656A/en unknown
- 1993-07-23 JP JP50627294A patent/JP3427937B2/ja not_active Expired - Fee Related
- 1993-07-23 ES ES93917323T patent/ES2139669T3/es not_active Expired - Lifetime
- 1993-07-23 AT AT93917323T patent/ATE184604T1/de not_active IP Right Cessation
- 1993-07-23 DE DE69326474T patent/DE69326474T2/de not_active Expired - Fee Related
- 1993-07-23 AU AU46872/93A patent/AU679452B2/en not_active Ceased
- 1993-07-23 HU HU9500559A patent/HUT71246A/hu active IP Right Revival
- 1993-07-23 WO PCT/US1993/006920 patent/WO1994004531A1/en active IP Right Grant
- 1993-07-23 EP EP93917323A patent/EP0656001B1/en not_active Expired - Lifetime
- 1993-07-23 DK DK93917323T patent/DK0656001T3/da active
- 1993-08-19 TW TW082106677A patent/TW404949B/zh not_active IP Right Cessation
- 1993-08-20 IL IL106748A patent/IL106748A0/xx unknown
- 1993-08-23 MX MX9305093A patent/MX9305093A/es not_active IP Right Cessation
-
1995
- 1995-02-23 NO NO950683A patent/NO303635B1/no not_active IP Right Cessation
- 1995-02-23 FI FI950842A patent/FI950842A/fi unknown
- 1995-03-01 US US08/396,833 patent/US5491141A/en not_active Expired - Fee Related
- 1995-03-01 US US08/396,945 patent/US5491142A/en not_active Expired - Fee Related
-
1999
- 1999-10-21 GR GR990402698T patent/GR3031602T3/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| GR3031602T3 (en) | 2000-01-31 |
| US5491142A (en) | 1996-02-13 |
| AU679452B2 (en) | 1997-07-03 |
| FI950842A0 (fi) | 1995-02-23 |
| NO950683L (no) | 1995-03-23 |
| WO1994004531A1 (en) | 1994-03-03 |
| DE69326474T2 (de) | 2000-02-17 |
| EP0656001B1 (en) | 1999-09-15 |
| NO950683D0 (no) | 1995-02-23 |
| FI950842A (fi) | 1995-02-23 |
| DE69326474D1 (de) | 1999-10-21 |
| AU4687293A (en) | 1994-03-15 |
| MX9305093A (es) | 1994-04-29 |
| NZ254656A (en) | 1995-12-21 |
| US5491141A (en) | 1996-02-13 |
| ES2139669T3 (es) | 2000-02-16 |
| JPH08500591A (ja) | 1996-01-23 |
| JP3427937B2 (ja) | 2003-07-22 |
| TW404949B (en) | 2000-09-11 |
| ATE184604T1 (de) | 1999-10-15 |
| CA2141563A1 (en) | 1994-03-03 |
| EP0656001A1 (en) | 1995-06-07 |
| HU9500559D0 (en) | 1995-04-28 |
| IL106748A0 (en) | 1993-12-08 |
| NO303635B1 (no) | 1998-08-10 |
| HUT71246A (en) | 1995-11-28 |
| CA2141563C (en) | 1998-07-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO923744D0 (no) | Nye 2-substituerte indan-2-mercaptoacetylamidderivater anvendbare som inhibitorer av enkefalinase og ace | |
| NO914092L (no) | Nye mercaptoacetylamid-derivater som er anvendbare som inhibitorer for enkefalinase og ace | |
| NO971684D0 (no) | Nye benzoxazoler | |
| NO923745L (no) | Nye 2-substituerte indan-2-carboxyalkylderivater anvendbare som inhibitorer av enkefalinase og ace | |
| NO942994L (no) | Aminoacetylmercaptoacetylamidderivater som er anvendbare som inhibitorer av enkefalinase og ACE | |
| MX9302906A (es) | Derivados de mercaptoacetilamida novedosos utiles como inhibidores de la encefalinasa. | |
| EA199900837A1 (ru) | Способ применения ингибиторов циклооксигеназы-2 для предупреждения сердечно-сосудистых расстройств | |
| DK0656001T3 (da) | Nye 2-substituerede indan-2-mercaptoacetylamid-tricycliske derivater til anvendelse som enkefalinasehæmmere | |
| NO308249B1 (no) | Nye indan-2-mercaptoacetylamid-disulfidderivater som er anvendbare som inhibitorer av enkefalinase | |
| NO921706L (no) | Nye 2-merkaptomethylen-tetrahydronafthalen- og indan-2-carboxamidderivater som enkefalinaseinhibitorer |